Clinical Trial of Recombinant Pneumococcal Protein Vaccine
NCT05622942
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Pneumonia
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions
BIOLOGICAL:
PBPV
BIOLOGICAL:
PPV23
Sponsor
CanSino Biologics Inc.